The 5th National Food Biotechnology Conference was held in Shanghai from October 25 to 27, 2024. Sponsored by the Chinese Society for Bioengineering and the Chinese Institute of Food Science and Technology, the conference focused on "Intelligent Biomanufacturing Empowers New Productivity in the Food Industry." The conference brought together four academicians of the Chinese Academy of Engineering, including Xie Jianping, Chen Jian, and Xie Mingyong, and Zhang Lixin, an academician of the European Academy of Sciences. Over 90 experts presented special reports, along with representatives from industry and investment funds, totaling over 600 attendees.

Academician Chen Jian: Shaping a new way of food production in the future

At the conference, Academician Chen Jian, an academician of the Chinese Academy of Engineering, special consultant of the bio-fermentation and future food industry chain, and director of the Technical Committee of the Chinese Institute of Bio-fermentation and Future Food Industry, gave a detailed introduction to "Future Food and Biomanufacturing", pointing out the positioning goals and vision of China's future food technology, that is, to have overall development advantages, seize the commanding heights, shape new ways of food production in the future, manufacture new models, new processing directions and new prevention and control systems, and replace traditional food manufacturing methods with high quality.

In recent years, terms like "diversified food supply system" and "big food concept" have frequently appeared in government reports. General Secretary Xi Jinping has pointed out that food biotechnology is a new engine driving innovation and rapid development in the food industry and a key tool for accelerating the development and formation of new high-quality productivity in the food industry. Previously, the General Office of the State Council issued the "Opinions of the General Office of the State Council on Practicing the Big Food Concept and Building a Diversified Food Supply System," which clearly outlined the direction and recommendations: "cultivate strategic emerging bio-industries, encourage and support the development of new food products, expand agricultural development space with modern agricultural technology and equipment, and develop a rich and diverse range of food varieties," "cultivate and develop bio-agriculture, explore new food resources...expand new sources of feed protein, and promote the application of microbial protein."

Fushine protein
Nutritionally superior meat alternative

Fushine Pharmaceuticals Vice Chairman Li Huiyue and his microbial protein team attended the conference and delivered a special report titled "Fushine Microbial Protein Industrialization Practice and Application in Food." In his speech, Vice Chairman Li Huiyue stated, "Fushine microbial protein (Weiran protein) breaks away from traditional agricultural and farmed methods of obtaining food protein. It boasts high technology, high efficiency, and high quality, making it a prime example of new-quality productivity." In terms of nutrition, Fushine Weiran protein demonstrates unique advantages and broad development prospects. Fushine Weiran protein is high in essential amino acids, and its composition closely matches human needs, making it easier for the body to absorb and utilize. Experimental findings indicate that Fushine Weiran protein is an excellent source of B vitamins and choline. Compared to traditional animal protein, Fushine Weiran protein is not subject to resource constraints or excessive environmental factors during production, providing a stable supply of high-quality protein and ensuring a continuous nutritional output. Furthermore, its production process is more controllable, effectively avoiding issues such as drug residues that may exist in traditional farming practices, further enhancing the safety and purity of the protein.

Fushine's protein has become a model for Fushine Pharmaceuticals' successful implementation of new-quality productivity. To effectively meet the growing and diversified demand for high-quality protein, Fushine's protein, with its advanced technology and innovative concepts, has successfully developed two product forms: dry-based protein and wet-based protein. Fushine's protein also has advantages in back-end applications and can be widely used in meat substitutes, protein beverages, high-protein baked products, plant-based dairy products, dietary supplements, high-protein nutritional supplements, and pet food. To date, Fushine has built a 1,200-ton microbial protein production line and has put it into normal production. The annual production capacity of 200,000 tons of microbial protein and comprehensive resource utilization project (Phase I) is under construction.

Over the past year, Fushine Pharmaceuticals has successfully transformed its microbial protein research findings into practical production, successfully obtaining certifications for four internationally recognized food safety systems: ISO22000, BRC, SQF, and HACCP, as well as HALAL certification. These achievements demonstrate the company's exceptional strength and efficient execution in the microbial protein field, providing a significant competitive advantage in the future. They lay a solid foundation for meeting market demand and driving industry development, and mark another milestone in Fushine Pharmaceuticals' pursuit of innovation and quality. Fushine's microbial protein will continue to contribute to meeting the diverse food consumption and nutritional health needs of the public with higher quality.